1
|
Comparison of the incidence of depression before and after endovascular treatment in patients with lower limb peripheral artery disease. Heart Vessels 2023; 38:164-170. [PMID: 35896724 DOI: 10.1007/s00380-022-02149-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Accepted: 07/20/2022] [Indexed: 01/10/2023]
Abstract
Depression is a chronic illness that affects mood, physical health, and overall vitality and quality of life. Depression has been associated with an increased risk of all-cause and cardiovascular mortality among patients with peripheral arterial disease (PAD). Therefore, this study aimed to compare the incidence of depression before and after endovascular treatment in patients with lower limb PAD. This is an important clinical issue considering the worldwide increase in PAD with the aging population and the known negative impact of depression on recovery. This was a retrospective sub-analysis of data from the Tokyo Peripheral Vascular Intervention Study using the TOMA-CODE registry. The presence and extent of depressive symptoms were evaluated using the patient health questionnaire (PHQ-9), with a depressive tendency score of ≥ 5. The PHQ-9 score was evaluated before endovascular treatment (EVT) and at 4 (± 1) weeks after EVT. The study population consisted of 87 patients who completed the PHQ-9 before EVT, with 76 completing the post-EVT PHQ-9. Of these 76, 19 had a pre-EVT score ≥ 5. Overall, there was no difference in the pre- and post-EVT scores (P = 0.091). There was no significant change in the 19 patients with a pre-EVT score ≥ 5 (mean 9.2 ± 4.4); however, there was a tendency to improve in the pre- to post-EVT score (mean, 6.9 ± 5.2; P = 0.059). Diabetes was a significant negative factor for pre- to post-EVT score improvement (P = 0.023). Overall, symptoms of depression showed the tendency to improve at 30 days post-EVT. However, diabetes was associated with lower improvement in symptoms.
Collapse
|
2
|
Nomoto H, Nozato T, Yamashita S, Suzuki M, Sugiyama T, Oumi T, Ohno M, Shimizu S, Ashikaga T, Satoh Y. Effect of Endovascular Treatment on Systemic Vascular Resistance in Patients with Lower-Limb Peripheral Artery Disease. Ann Vasc Dis 2020; 13:377-383. [PMID: 33391554 PMCID: PMC7758593 DOI: 10.3400/avd.oa.20-00086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Objective: Endovascular treatment (EVT) for lower-limb peripheral artery disease patients reduces blood pressure (BP) and improves prognosis. This study retrospectively examined hemodynamics during EVT to clarify the mechanism. Materials and Methods: Systemic vascular resistance (SVR) was measured using a noninvasive continuous cardiac output monitoring system during EVT. Furthermore, ankle brachial index was measured before and after EVT. Results: The study included 88 lesions of 56 patients (hypertension in 98%). SVR significantly decreased from 2409.1±746.8 dynes·s·cm-5 to 2033.7±635.0 dynes·s·cm-5 (p<0.0001). The difference in SVR before and after EVT was significantly greater in the Fontaine IV group than in the Fontaine IIa group (554.7±406.6 dynes·s·cm-5 vs. 312.9±245.7 dynes·s·cm-5, p=0.0151). The change in SVR was correlated with a change in mean BP in the upper limb (p=0.0026). When the change in pressure gradient between the upper limb and the diseased lower limb was large, mean BP of the upper limb significantly decreased (p=0.0022). Conclusion: EVT can reduce SVR and BP by canceling the pressure gradient between central BP and diseased lower-limb BP.
Collapse
Affiliation(s)
- Hidetsugu Nomoto
- Department of Cardiovascular Medicine, Ome Municipal General Hospital, Ome, Tokyo, Japan
| | - Toshihiro Nozato
- Department of Cardiovascular Medicine, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan.,Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan
| | - Shu Yamashita
- Department of Cardiovascular Medicine, Kameda General Hospital, Kamogawa, Chiba, Japan
| | - Masahito Suzuki
- Department of Cardiovascular Medicine, National Hospital Organization, Disaster Medical Center, Tachikawa, Tokyo, Japan
| | - Tomoyo Sugiyama
- Department of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan
| | - Tetsuo Oumi
- Department of Cardiovascular Medicine, National Hospital Organization, Disaster Medical Center, Tachikawa, Tokyo, Japan
| | - Masakazu Ohno
- Department of Cardiovascular Medicine, National Hospital Organization, Disaster Medical Center, Tachikawa, Tokyo, Japan
| | - Shigeo Shimizu
- Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.,Department of Cardiovascular Medicine, National Hospital Organization, Disaster Medical Center, Tachikawa, Tokyo, Japan
| | - Takashi Ashikaga
- Department of Cardiovascular Medicine, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan.,Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan
| | - Yasuhiro Satoh
- Department of Cardiovascular Medicine, Hiratsuka Kyosai Hospital, Hiratsuka, Kanagawa, Japan
| |
Collapse
|